Apple Inc (NASDAQ:AAPL, ETR:APC) may be grappling with tariff uncertainty and a sluggish AI rollout, but investors should not lose sight of its long-term strengths. That is the message from Wedbush, which reiterated its “outperform” rating and $270 price target, citing growing confidence in Apple's ability to manage geopolitical risks while preserving margin and scale.

WIX introduces Wixel, an AI-powered design platform enabling anyone to create professional visuals effortlessly, with Pro upgrades available.

NRIM, NNI and ARMN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 16, 2025.

MCD benefits from robust global expansion plans and solid digital and loyalty strategies.

Examine the evolution of Gen Digital's (GEN) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Perpetua Resources Corp. (NASDAQ:PPTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/perpetua-resources-corp-lawsuit-submission-form?prid=148894&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/napco-security-technologies-inc-lawsuit-submission-form-2?prid=148895&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. ("Organon & Co.") (NYSE:OGN) concerning possible violations of federal securities laws. On May 1, 2025, Organon reported mixed Q1 FY25 results, missing expectations on revenue decline of 7% y/y to $1.51B.

- *6x Platinum*: SZA's "SOS" album sells 6M+ units, with 100M+ streams on Billboard-topping singles, driving significant recurring revenues.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cable One, Inc. ("Cable One, Inc.") (NYSE:CABO) concerning possible violations of federal securities laws. On May 2, 2025, Cable One missed earnings expectations by nearly $8 and suspended its dividend.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has delayed an approval decision on Cytokinetics' experimental hypertrophic obstructive cardiomyopathy drug aficamten so it can have more time to review the company's proposed risk management plan.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of EchoStar Corporation ("EchoStar Corporation") (NASDAQ:SATS) concerning possible violations of federal securities laws. The Wall Street Journal reported on May 12, 2025, that the Federal Communications Commission had notified EchoStar that it would be investigating the Company's compliance with federal requirements to build a nationwide 5G network.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cleveland-Cliffs Inc. ("Cleveland-Cliffs Inc.") (NYSE:CLF) concerning possible violations of federal securities laws. Cleveland-Cliffs issued a press release on May 7, 2025, reporting its financial results for the first quarter of 2025.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=148904&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=148899&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.

ROCHESTER, N.Y. , May 16, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of AI-powered smart glasses, waveguides, and Augmented Reality (AR) technologies, today acknowledged a public post made by Amazon on LinkedIn, which highlighted the use of Vuzix smart glasses to enhance warehouse operations.

BILZ offers capital preservation and liquidity by investing in ultra-short-term government debt, ideal for risk-averse investors amid rising default rates. Despite active management, BILZ's yield lags behind leading peers like SGOV, failing to deliver on its higher yield promise. Current macro risks, including elevated federal debt and default concerns, reinforce the need for safe, short-duration assets in portfolios.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Myriad Genetics, Inc. ("Myriad Genetics, Inc.") (NASDAQ:MYGN) concerning possible violations of federal securities laws. Myriad released its first quarter 2025 financial results on May 6, 2025, revealing "revenue of $196 million declined by 3% year-over-year" and "pharmacogenomics revenue declined by 20% year-over-year due to UnitedHealthcare (UNH) reducing coverage of GeneSight®.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Ichor Holdings, Ltd. ("Ichor Holdings, Ltd.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Canopy Growth To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / If you suffered losses exceeding $50,000 in Canopy Growth between May 30, 2024 and February 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential …